BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19637383)

  • 41. An unusual presentation of inflammatory bowel disease.
    Adams DJ; Colombo JM
    Mil Med; 2012 Feb; 177(2):240-2. PubMed ID: 22360074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
    Sorrentino D; Paviotti A
    Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
    [No Abstract]   [Full Text] [Related]  

  • 43. Deposition of complement product C4d in anti-glomerular basement membrane glomerulonephritis.
    Batal I; Chalasani G; Wu C; Shapiro R; Bastacky S; Randhawa P
    Am J Kidney Dis; 2009 Jun; 53(6):1098-101. PubMed ID: 19084308
    [No Abstract]   [Full Text] [Related]  

  • 44. Education and imaging. Gastrointestinal: gastric Crohn's disease.
    Tseng TC; Chang YT; Wong JM
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1690. PubMed ID: 17845696
    [No Abstract]   [Full Text] [Related]  

  • 45. Increased levels of circulating platelet derived microparticles in Crohn's disease patients.
    Tziatzios G; Polymeros D; Spathis A; Triantafyllou M; Gkolfakis P; Karakitsos P; Dimitriadis G; Triantafyllou K
    Scand J Gastroenterol; 2016 Oct; 51(10):1184-92. PubMed ID: 27191369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mesalazine is effective in Crohn disease].
    Quartarolo JP
    Ugeskr Laeger; 2005 Apr; 167(16):1767. PubMed ID: 15898611
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract]   [Full Text] [Related]  

  • 48. Mesalamine-induced myocarditis following diagnosis of Crohn's disease: a case report.
    Galvão Braga C; Martins J; Arantes C; Ramos V; Vieira C; Salgado A; Magalhães S; Correia A
    Rev Port Cardiol; 2013 Sep; 32(9):717-20. PubMed ID: 23993290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-glomerular basement membrane antibodies.
    Silvariño R; Noboa O; Cervera R
    Isr Med Assoc J; 2014 Nov; 16(11):727-32. PubMed ID: 25558706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary artery ectasia in Crohn's disease.
    Korovesis T; Katritsis G; Koudounis P; Zografos T
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30344153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-aminosalicylic acid dependency in Crohn's disease: a Danish Crohn Colitis Database study.
    Duricova D; Pedersen N; Elkjaer M; Jensen JK; Munkholm P
    J Crohns Colitis; 2010 Nov; 4(5):575-81. PubMed ID: 21122562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mesalazine is effective in Crohn disease 2].
    Quartarolo JP; Laegemidler F; Eskerod O
    Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
    [No Abstract]   [Full Text] [Related]  

  • 53. [Mesalazine is effective in Crohn disease 1].
    Fallingborg J; Langholz E; Christensen LA; Munkholm P; Dahlerup JF
    Ugeskr Laeger; 2005 Mar; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
    [No Abstract]   [Full Text] [Related]  

  • 54. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
    J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
    [No Abstract]   [Full Text] [Related]  

  • 55. A young woman with recurrent perianal sepsis.
    Kaye TL; O'Connor A; Burke D; Tolan DJ
    BMJ; 2015 Apr; 350():h1969. PubMed ID: 25908600
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W; Stange EF;
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract]   [Full Text] [Related]  

  • 57. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
    Yamamoto T; Umegae S; Matsumoto K
    Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB; Klemt-Kropp M
    Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis.
    Borza DB
    Nephron Exp Nephrol; 2007; 106(2):e37-43. PubMed ID: 17570938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
    Neĭman KP; Rumiantsev VG
    Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.